PortfoliosLab logo
CME vs. NDAQ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CME and NDAQ is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

CME vs. NDAQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CME Group Inc. (CME) and Nasdaq, Inc. (NDAQ). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

CME:

2.00

NDAQ:

1.41

Sortino Ratio

CME:

2.64

NDAQ:

2.13

Omega Ratio

CME:

1.36

NDAQ:

1.31

Calmar Ratio

CME:

2.52

NDAQ:

1.83

Martin Ratio

CME:

9.70

NDAQ:

6.59

Ulcer Index

CME:

3.83%

NDAQ:

5.68%

Daily Std Dev

CME:

18.16%

NDAQ:

23.94%

Max Drawdown

CME:

-77.50%

NDAQ:

-68.48%

Current Drawdown

CME:

-2.99%

NDAQ:

-1.89%

Fundamentals

Market Cap

CME:

$98.74B

NDAQ:

$47.02B

EPS

CME:

$9.93

NDAQ:

$2.21

PE Ratio

CME:

27.59

NDAQ:

37.06

PEG Ratio

CME:

8.12

NDAQ:

1.64

PS Ratio

CME:

15.74

NDAQ:

6.02

PB Ratio

CME:

3.55

NDAQ:

4.04

Total Revenue (TTM)

CME:

$6.28B

NDAQ:

$7.81B

Gross Profit (TTM)

CME:

$5.43B

NDAQ:

$4.28B

EBITDA (TTM)

CME:

$4.98B

NDAQ:

$2.52B

Returns By Period

In the year-to-date period, CME achieves a 19.56% return, which is significantly higher than NDAQ's 6.29% return. Over the past 10 years, CME has underperformed NDAQ with an annualized return of 15.87%, while NDAQ has yielded a comparatively higher 18.74% annualized return.


CME

YTD

19.56%

1M

5.70%

6M

26.92%

1Y

35.89%

5Y*

13.38%

10Y*

15.87%

NDAQ

YTD

6.29%

1M

14.24%

6M

4.64%

1Y

33.42%

5Y*

18.71%

10Y*

18.74%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CME vs. NDAQ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CME
The Risk-Adjusted Performance Rank of CME is 9494
Overall Rank
The Sharpe Ratio Rank of CME is 9696
Sharpe Ratio Rank
The Sortino Ratio Rank of CME is 9292
Sortino Ratio Rank
The Omega Ratio Rank of CME is 9292
Omega Ratio Rank
The Calmar Ratio Rank of CME is 9595
Calmar Ratio Rank
The Martin Ratio Rank of CME is 9595
Martin Ratio Rank

NDAQ
The Risk-Adjusted Performance Rank of NDAQ is 9090
Overall Rank
The Sharpe Ratio Rank of NDAQ is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of NDAQ is 8888
Sortino Ratio Rank
The Omega Ratio Rank of NDAQ is 8888
Omega Ratio Rank
The Calmar Ratio Rank of NDAQ is 9292
Calmar Ratio Rank
The Martin Ratio Rank of NDAQ is 9090
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CME vs. NDAQ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for CME Group Inc. (CME) and Nasdaq, Inc. (NDAQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current CME Sharpe Ratio is 2.00, which is higher than the NDAQ Sharpe Ratio of 1.41. The chart below compares the historical Sharpe Ratios of CME and NDAQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

CME vs. NDAQ - Dividend Comparison

CME's dividend yield for the trailing twelve months is around 3.80%, more than NDAQ's 1.17% yield.


TTM20242023202220212020201920182017201620152014
CME
CME Group Inc.
3.80%4.48%4.58%5.05%3.00%3.24%2.74%2.42%4.20%4.90%5.41%4.38%
NDAQ
Nasdaq, Inc.
1.17%1.22%1.48%1.27%1.00%1.46%1.73%2.08%1.90%1.80%1.55%1.21%

Drawdowns

CME vs. NDAQ - Drawdown Comparison

The maximum CME drawdown since its inception was -77.50%, which is greater than NDAQ's maximum drawdown of -68.48%. Use the drawdown chart below to compare losses from any high point for CME and NDAQ. For additional features, visit the drawdowns tool.


Loading data...

Volatility

CME vs. NDAQ - Volatility Comparison

CME Group Inc. (CME) has a higher volatility of 7.45% compared to Nasdaq, Inc. (NDAQ) at 5.05%. This indicates that CME's price experiences larger fluctuations and is considered to be riskier than NDAQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

CME vs. NDAQ - Financials Comparison

This section allows you to compare key financial metrics between CME Group Inc. and Nasdaq, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B1.20B1.40B1.60B1.80B2.00B20212022202320242025
1.64B
2.09B
(CME) Total Revenue
(NDAQ) Total Revenue
Values in USD except per share items

CME vs. NDAQ - Profitability Comparison

The chart below illustrates the profitability comparison between CME Group Inc. and Nasdaq, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%20212022202320242025
87.4%
82.9%
(CME) Gross Margin
(NDAQ) Gross Margin
CME - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, CME Group Inc. reported a gross profit of 1.44B and revenue of 1.64B. Therefore, the gross margin over that period was 87.4%.

NDAQ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Nasdaq, Inc. reported a gross profit of 1.73B and revenue of 2.09B. Therefore, the gross margin over that period was 82.9%.

CME - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, CME Group Inc. reported an operating income of 1.11B and revenue of 1.64B, resulting in an operating margin of 67.5%.

NDAQ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Nasdaq, Inc. reported an operating income of 547.00M and revenue of 2.09B, resulting in an operating margin of 26.2%.

CME - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, CME Group Inc. reported a net income of 956.20M and revenue of 1.64B, resulting in a net margin of 58.2%.

NDAQ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Nasdaq, Inc. reported a net income of 395.00M and revenue of 2.09B, resulting in a net margin of 18.9%.